AVI-7537
- Generic Name
- AVI-7537
- Drug Type
- Biotech
- Unique Ingredient Identifier
- 0P93LDFNTU
- Background
AVI-7537 is an antisense molecule that binds to the Ebola virus mRNA to prevent the viral replication. AVI-7537 is under investigation in clinical trial NCT01593072 (A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers).
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers
Phase 1
Withdrawn
- Conditions
- Ebola Hemorrhagic Fever
- Interventions
- Other: Normal Saline Solution (NSS)
- First Posted Date
- 2012-05-07
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- Sarepta Therapeutics, Inc.
- Registration Number
- NCT01593072
- Locations
- 🇺🇸
Quintiles Phase I Services, Overland Park, Kansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath